Branched Chain Amino Acids for Concussion (HIT HEADS Trial)

"Presently, 6 clinical trials of Branched Chain Amino Acids are underway with 1 research project in its final phase. The majority of these experiments originate from Columbus, Ohio; nevertheless, 23 other trial sites exist for this medication."

"This clinical trial is enrolling 50 individuals, aged between 11 and 34 years old who have sustained a traumatic brain injury. Other eligibility criteria includes: being of any gender/race, having access to email and the internet on a daily basis (if female), passing an urine pregnancy test, demonstrating the capacity to grant informed consent or assent in case they are minors and having been diagnosed by a certified medical practitioner within 72 hours prior to enrollment."

"Affirmative. The clinical trial registry on clinicaltrials.gov attests to this medical investigation's ongoing recruitment process, which began on January 1st 2014 and was last revised on March 22nd 2022. This research is looking for 50 volunteers from a single site."

"Affirmative. Information hosted on clinicaltrials.gov indicates that this medical study, which was initially posted in January 1st 2014, is actively inviting participants to join the trial. The team plans to recruit a total of 50 patients from one site location."

"This trial has specified age requirements of 11 to 34 years old, with 29 studies recruiting participants younger than 18 and 38 focused on individuals above 65."

"The safety of Branched Chain Amino Acids was rated a 2, as the drug is only in Phase 2 trials and has yet to demonstrate its efficacy."

"Branched Chain Amino Acids are frequently implemented to treat conditions of parenteral nutrition, as well as gestational term birth, uremia, and various protein metabolism disorders."